CRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth KnowingZacks Investment Research • 06/26/24
Is Most-Watched Stock CRISPR Therapeutics AG (CRSP) Worth Betting on Now?Zacks Investment Research • 06/24/24
CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to NoteZacks Investment Research • 06/20/24
CRISPR Therapeutics (CRSP) Presents at Goldman Sachs 45th Annual Global Healthcare Conference - Company Call TranscriptSeeking Alpha • 06/11/24
CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should KnowZacks Investment Research • 06/11/24
Crispr Therapeutics, Futurism-Turning-Commercial, Defies 'Valuation' (Technical Analysis)Seeking Alpha • 06/10/24
Why Is CRISPR Therapeutics (CRSP) Up 12% Since Last Earnings Report?Zacks Investment Research • 06/07/24
CRISPR Therapeutics AG (CRSP) Jefferies 2024 Global Healthcare Conference (Transcript)Seeking Alpha • 06/06/24
CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on ItZacks Investment Research • 05/29/24
CRISPR Therapeutics Strengthens Executive Leadership Team with Key AppointmentsGlobeNewsWire • 05/23/24